• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保险D部分:简化该计划并提高向受益人的信息价值。

Medicare Part D: simplifying the program and improving the value of information for beneficiaries.

作者信息

Hoadley Jack

机构信息

Health Policy Institute, Georgetown University, USA.

出版信息

Issue Brief (Commonw Fund). 2008 May;39:1-15.

PMID:18536148
Abstract

Many Medicare beneficiaries signed up for the new Part D benefit during the program's first two years. Subsequently, a significant majority of them reported that the benefit was too complicated, and some observers suggest that the complexity may have thwarted some beneficiaries from finding the plan that was best for them. Meanwhile, more than 4 million of those eligible failed to enroll at all. Although some degree of standardization may occur naturally as the market evolves, steps can be taken to simplify the program and make it easier for beneficiaries to make good choices among plans--and for them to enroll in the first place. This issue brief considers specific options for simplifying Part D in several areas: standardizing the benefit descriptions and procedures used by plans and the Medicare program; further standardization of the plan's benefit parameters, particularly the rules for cost-sharing; and changes to the rules governing plan formularies.

摘要

许多医疗保险受益人在该计划的头两年报名参加了新的D部分福利。随后,绝大多数受益人表示该福利过于复杂,一些观察人士认为,这种复杂性可能阻碍了一些受益人找到最适合他们的计划。与此同时,超过400万符合条件的人根本没有参保。尽管随着市场的发展可能会自然出现一定程度的标准化,但仍可以采取措施简化该计划,让受益人更容易在各计划中做出明智选择,并首先让他们能够参保。本问题简报考虑了在几个方面简化D部分的具体选项:规范各计划和医疗保险计划所使用的福利描述及程序;进一步规范计划的福利参数,尤其是费用分摊规则;以及修改有关计划药品目录的规则。

相似文献

1
Medicare Part D: simplifying the program and improving the value of information for beneficiaries.医疗保险D部分:简化该计划并提高向受益人的信息价值。
Issue Brief (Commonw Fund). 2008 May;39:1-15.
2
Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis.医疗保险D部分对类风湿性关节炎患者获得专科生物药物及费用分担的影响。
Arthritis Rheum. 2009 Jun 15;61(6):745-54. doi: 10.1002/art.24560.
3
Medicare Part D: how do vulnerable beneficiaries fare?医疗保险D部分:弱势受益人的情况如何?
Issue Brief (Commonw Fund). 2008 Apr;35:1-11.
4
Voluntary disenrollment from Medicare advantage plans: valuable signals of market performance.主动退出医疗保险优势计划:市场表现的重要信号。
Am J Manag Care. 2007 Dec;13(12):677-84.
5
Medicare Advantage: options for standardizing benefits and information to improve consumer choice.医疗保险优势:规范福利和信息以改善消费者选择的方案。
Issue Brief (Commonw Fund). 2008 Apr;33:1-19.
6
Medicare Part D formulary coverage since program inception: are beneficiaries choosing wisely?自医疗保险D部分药品目录覆盖计划启动以来:受益人的选择明智吗?
Am J Manag Care. 2008 Nov;14(11 Suppl):SP29-35.
7
Beneficiary price sensitivity in the Medicare prescription drug plan market.医疗保险处方药计划市场中的受益方价格敏感性。
Health Econ. 2010 Jan;19(1):88-100. doi: 10.1002/hec.1451.
8
Understanding the Medicare Part D prescription program: partnerships for beneficiaries and health care professionals.了解医疗保险D部分处方药计划:受益人与医疗保健专业人员的合作关系
Policy Polit Nurs Pract. 2007 Aug;8(3):170-81. doi: 10.1177/1527154407309048.
9
Medicare Part D: practical practice information for healthcare providers.
J Am Acad Nurse Pract. 2006 Oct;18(10):457-62. doi: 10.1111/j.1745-7599.2006.00162.x.
10
Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.药品和医疗器械:医疗保险D部分。年终问题简报。
Issue Brief Health Policy Track Serv. 2009 Jan 5:1-26.

引用本文的文献

1
Assessment of medicare part d communications to beneficiaries.医疗保险D部分与受益人的沟通评估
Am Health Drug Benefits. 2010 Sep;3(5):310-7.
2
Psychometric properties of an instrument to assess Medicare beneficiaries' prescription drug plan experiences.一种用于评估医疗保险受益人的处方药计划体验的工具的心理测量特性。
Health Care Financ Rev. 2009 Spring;30(3):41-53.
3
How much choice is too much? The case of the Medicare prescription drug benefit.多少选择才算过多?医疗保险处方药福利的案例。
Health Serv Res. 2009 Aug;44(4):1157-68. doi: 10.1111/j.1475-6773.2009.00981.x. Epub 2009 May 26.